About Lyfas
Lyfas is a Healthcare company based in Bengaluru (India) founded in 2017. Provider of AI-based predictive and preventive digital health test and home remedy. Lyfas has raised $2.26 million across 6 funding rounds from investors including Indian Institute of Technology Kanpur, Startup Karnataka and Startup Basket. The company has 1 employees. Lyfas was last valued at $2.93 million in March 2022. Its Indian entity Acculi Labs Private Limited reported revenue of ₹15.8 Lakh. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations.
Company details
Provider of a predictive and preventive digital health test and home remedy. It offers smartphone technology validated by hospitals. It provides features for health tests by clinical-grade application to capture blood volume changes in the capillary. It also offers AI and Heuristics for a report of MOBILE(Mind, Organ, Body, Illness, Lifestyle, and Emotions). Associated clinicians evaluate the reports and assistants ask questions related to current and past health, family history. The company delivers all the services that are needed for primary preventive predictive health such as screening, early diagnosis, and root-cause analysis, monitoring, therapeutic, etc.
- Headquarters Bengaluru, India
- Employees 1
- Stage Minicorn
- SectorsHealthcare
- Website lyfas.com/cgi-sys/suspendedpage.cgi
- Social LinkedIn X Facebook
- Legal Name Acculi Labs Private Limited
- Date of Incorporation 30 May, 2017
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹15.8 Lakh
FY 2022 · +29% YoY
- Net Loss-₹46.4 Lakh
FY 2022 · -295% margin
- EBITDA-₹41.6 Lakh
FY 2022 · -264% margin
- Total Equity Funding$2.26M (USD)
in 6 rounds
- Latest Funding Round$1.5M (USD), Seed
Aug 2024
- InvestorsIndian Institute of Technology Kanpur
& 17 more
- Employee Count1
Associated legal entities of Lyfas
Lyfas operates through Acculi Labs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Acculi Labs Private Limited CIN U72900KA2017PTC103431 | Active | 30 May 2017 | Bangalore, Karnataka | ₹0.2 Cr | 3 | View details |
Funding Insights of Lyfas
Lyfas has successfully raised a total of $2.26M across 6 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.26M
- Total Rounds 6
- Last Round Seed — $1.5M
- Investors Count 18
All 6 funding rounds of Lyfas with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2024 | $1.5M | Seed | – | – | |
| Oct 2022 | Seed | – | Indian Institute of Technology Kanpur | – | |
| Mar 2022 | $31,373 | Angel Round | $2.93M | Ramakrishna Ravi | – |
| Oct 2020 | $681,450 | Seed | – | PirE Ventures | – |
| Aug 2019 | $47,738 | Seed | $452,266 | Startup Basket, Chandrashekar Kupperi | |
| Jun 2018 | Grant | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Mar 2022 | $2.93M | •••••••• |
Last known valuation $2.93M (Mar 2022). 18 investors in total: 5 institutional and 13 angel.
Investors in Lyfas
Lyfas has secured backing from 18 investors, including institutional, angel, and venture fund investors. Prominent investors backing the company include Indian Institute of Technology Kanpur, Startup Karnataka and Startup Basket.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Potato farming, grain marketing, and equipment services in Maine. | 2020 | pireventures.com | Mumbai, India | |
| sabiholding.com | ||||
Multiple engineering courses and degrees are offered at the institute. | 1959 | iitk.ac.in | Kanpur, India | |
Startup Basket offers comprehensive services in clinical development, testing, and product validation. | 2017 | startupbasket.net | Bengaluru, India | |
Support for startups in Karnataka is delivered through policies, funding, and networking services. | 2004 | missionstartupkarnataka.org | Bengaluru, India | |
RR Ramakrishna Ravi | unknown_ac4a48af86eb42c19 | |||
CK Chandrashekar Kupperi | Angel investor, founder of ANOVA, focusing on tech startups in India. | unknown_86936234ec4b4ae98 | ||
PY Priyesh Yegnesh Kapadia | unknown_32dc3fd22d0c45e1b | |||
MP Moushmi Priyesh Kapadia | unknown_39b5438eacc249329 | |||
GK G K Jaishankar | unknown_75f6b55aefd24eacb |
Investor details for Lyfas
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Acculi Labs Private Limited (Lyfas)
Acculi Labs Private Limited is the primary company behind Lyfas. The board of Acculi Labs Private Limited currently have 3 directors; the longest-serving is Rupam Das, appointed in 2017. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rupam Das DIN 07796010 | Director | 30 May 2017 | 9 yrs 4 mo | Acculi Labs Private Limited |
| Moumita Das DIN 07834106 | Director | 30 May 2017 | 9 yrs 4 mo | Acculi Labs Private Limited |
| Akbar DIN 08891701 | Director | 26 Sep 2020 | 6 yrs | Acculi Labs Private Limited |
Financials of Lyfas
Figures of Acculi Labs Private Limited, the primary company behind Lyfas, for FY 2022. Revenue was ₹15.8 Lakh (+29% year on year). Net loss was -₹46.4 Lakh (-295% margin). EBITDA was -₹41.6 Lakh (-264% margin). Revenue has grown at a compounded annual rate of +13% over three years.
- ₹15.8 LakhRevenue · FY 2022 · +29% YoY
- -₹46.4 LakhNet loss · -295% margin
- -₹41.6 LakhEBITDA · -264% margin
- ₹1.4 LakhPaid-up capital
- +13%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Acculi Labs Private Limited are on its company page.
Detailed financial statements for Lyfas
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Lyfas
4 dated milestones of Lyfas across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Lyfas is founded.
- Funding First funding round.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Seed, of $1.5M.
Web traffic of Lyfas
The website of Lyfas (lyfas.com) receives about 1.5K visits a month.
- Monthly visits1.5K
▼ 50.2% vs previous month
Websites whose visitors overlap most with Lyfas. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| gomedii.com | 100% | 27.1K | #1,186,294 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lyfas
Complete news archive for Lyfas
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lyfas
Lyfas was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Lyfas is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Lyfas is a funded company, having raised a total of $2.26M across 6 funding rounds to date.
Lyfas has 1 employees.
The primary company behind Lyfas, Acculi Labs Private Limited, reported revenue of ₹15.8 Lakh for FY 2022, up 29% year on year.
Provider of a predictive and preventive digital health test and home remedy. It offers smartphone technology validated by hospitals. It provides features for health tests by clinical-grade application to capture blood volume changes in the capillary. It also offers AI and Heuristics for a report of MOBILE(Mind, Organ, Body, Illness, Lifestyle, and Emotions). Associated clinicians evaluate the reports and assistants ask questions related to current and past health, family history. The company delivers all the services that are needed for primary preventive predictive health such as screening, early diagnosis, and root-cause analysis, monitoring, therapeutic, etc.
Lyfas has 18 investors. Key investors include Indian Institute of Technology Kanpur, Startup Karnataka, Startup Basket, PirE Ventures, and Sabi Holding India.
The valuation of Lyfas is $2.93M as of Mar 2022.
Lyfas operates through Acculi Labs Private Limited.
The legal entities of Lyfas currently have 3 directors, including Rupam Das, Akbar, Moumita Das.